Intensity Therapeutics, Inc.
INTS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16,268 | -$10,538 | -$7,582 | -$7,896 |
| Dep. & Amort. | $0 | $0 | $179 | $0 |
| Deferred Tax | $0 | $0 | -$179 | $0 |
| Stock-Based Comp. | $3,073 | $1,398 | $1,169 | $0 |
| Change in WC | -$2,101 | -$633 | $757 | $177 |
| Other Non-Cash | $76 | $2,568 | $179 | $892 |
| Operating Cash Flow | -$15,220 | -$7,205 | -$5,477 | -$6,827 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$3,056 | -$15,053 | $0 | $0 |
| Inv. Sales/Matur. | $9,410 | $9,030 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $6,354 | -$6,023 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $230 | $2,250 | $2,000 |
| Stock Issued | $3,232 | $22,425 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$332 | -$2,183 | $0 | $50 |
| Financing Cash Flow | $2,900 | $20,472 | $2,250 | $2,050 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,966 | $7,244 | -$3,227 | -$4,777 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,556 | $1,312 | $4,539 | $9,316 |
| End Cash | $2,590 | $8,556 | $1,312 | $4,539 |
| Free Cash Flow | -$15,220 | -$7,205 | -$5,477 | -$6,827 |